Mechanisms of ferric citrate uptake by human hepatoma cells

29Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The mechanisms of uptake of non-transferrin-bound iron by human hepatoma cells (HuH7) were investigated using 59Fe-citrate and [14C]citrate. The amount of iron associated with the cells increased linearly with time, whereas citrate uptake reached a plateau after 45 min, resulting in a cellular accumulation of iron over citrate. The cells displayed high-affinity membrane binding sites for citrate with maximum binding of 118 ± 17 pmol citrate/mg protein and a dissociation constant of 21 ± 2 μM (n = 3). Iron uptake was saturable with a maximum uptake rate of 1.95 ± 0.43 pmol · mg protein-1 · min-1 and an apparent Michaelis constant of 1.1 ± 0.1 μM. Nonradioactive ferric citrate and citrate inhibited 59Fe uptake to a similar degree. This suggests that the uptake of citrate-bound iron is dependent on either binding to specific citrate binding sites or the concentration of unbound iron. The uptake of iron was inhibited by ferricyanide (>100 μM) and ferrous iron chelators but stimulated by ferrocyanide and ascorbate, suggesting that the iron is reduced from Fe3+ to Fe2+ and transported into the cell by an iron carrier-mediated step.

Cite

CITATION STYLE

APA

Trinder, D., & Morgan, E. (1998). Mechanisms of ferric citrate uptake by human hepatoma cells. American Journal of Physiology - Gastrointestinal and Liver Physiology, 275(2 38-2). https://doi.org/10.1152/ajpgi.1998.275.2.g279

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free